Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy

Journal of Immunotherapy

Volumn 19, Issue 1, 1996, Pages 81-84

  Rosenberg, Steven A ^a   White, Donald E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antigens, melanocyte differentiation; Immunotherapy; Melanoma; Vitiligo

Indexed keywords

DIFFERENTIATION ANTIGEN; INTERLEUKIN 2;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; VITILIGO;

ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; HUMANS; IMMUNOTHERAPY, ACTIVE; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; VITILIGO;

EID: 0030008301     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-199601000-00009     Document Type: Article

References (20)

1. Rosenberg SA, Packard BS, Aebersold PM, et al. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: preliminary report. N Engl J Med 1988;319:1676-80.
2. Rosenberg SA, Yannelli JR, Topalian SL, et al. Treatment of patients with metastatic melanoma with autologous tumorinfiltrating lymphocytes and interleukin-2. J Natl Cancer Inst 1994;86:1159-66.
3. Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-62.
4. Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-19.
5. Robbins PF, El-Gamil M, Kawakami Y, Rosenberg SA. Recognition of tyrosinase by tumor infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 1994;54:3124-6.
6. Wang R, Robbins PF, Kawakami Y, Kang X, Rosenberg SA. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31 restricted tumor-infiltrating lymphocytes. J Exp Med 1995;181:799-804.
7. Schallreuter KU, Levenig C, Berger J. Vitiligo and cutaneous melanoma: a case study. Dermatologica 1991;183:239-45.
8. Bystryn J-C, Rigel D, Friedman RJ, Kopf A. Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol 1987;123:1053-5.
9. Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB. Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 1983;9: 689-95.
10. Shoenfeld Y, Yecheskel G, Chaitchik S, Azizi E, Fishman P. Vitiligo and melanoma-associated hypopigmentation: a similar appearance but a different mechanism. Cancer Immunol Immunother 1994;38:411-6.
11. Richards JM, Mehta N, Ramming K, Skosey P. Sequential chemoimmunotherapy in the treatment of metastatic melanoma. J Clin Oncol 1992;10:1338-43.
12. Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985;313:1485-92.
13. Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 1987;316:889-97.
14. Rosenberg SA, Lotze MT, Yang JC, et al. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 1989;210:474-84.
15. Rosenberg SA. The immunotherapy and gene therapy of cancer. J Clin Oncol 1992;10:180-99.
16. Brichard V, Van Pel A, Wolfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178: 489-95.
17. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 1994;91:9461-5.
18. Dunston GM, Halder RM. Vitiligo is associated with HLA-DR4 in black patients. Arch Dermatol 1990;126:56-60.
19. Van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
20. Coulie PG, Weynants P, Lehmann F. et al. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. J Immunother 1993;14:104-9.